Showing 2841-2850 of 4063 results for "".
- EMA Handed Down Fewer Positive Drug Opinions in 2018https://modernod.com/news/ema-handed-down-fewer-positive-drug-opinions-in-2018/2476203/In 2018, the European Medicines Agency (EMA) recommended marketing authorization for 84 new medicines, down from 92 in 2017, according to a report in Medscape. The 84 medicines given a thumbs up by EMA’s Committee for Medicin
- EyePoint Pharmaceuticals to Launch Dexycu and Yutiq in First Quarter of 2019https://modernod.com/news/eyepoint-pharmaceuticals-to-launch-dexycu-and-yutiq-in-first-quarter-of-2019/2476226/During a corporate update, EyePoint Pharmaceuticals executives said they expect to launch both Dexycu (dexamethasone intraocular suspension 9%) and Yutiq (fluocinolone acetonide intravitreal implant 0.18 mg) in the first quarter of calendar 2019. “EyePoint has made significant progress in
- 2018 Best of Eyetubehttps://modernod.com/news/2018-best-of-eyetube/2476238/Cataract & Refractive Surgery Today (CRST) has compiled the best content of 2018 from Eyetube.net, the leading video resource for ophthalmologists. Below are descriptions of a few of the top videos. To view all of the videos and their descriptions, click
- iSTAR Medical’s MINIject Maintains Exceptional Results in First-in-Human Trial One Year Post-Surgery (STAR-I)https://modernod.com/news/istar-medicals-miniject-maintains-exceptional-results-in-first-in-human-trial-one-year-post-surgery-star-i/2476244/iSTAR Medical announced 1-year results of the first-in-human, microinvasive glaucoma surgery (MIGS) STAR-I trial, for the MINIject device in a standalone setting. Results demonstrate that MINIject is safe and highly effective in achieving significant IOP reduction, as well as easing medication bu
- Market Scope: Global Dry Eye Products Market to Total $6.2 Billion in 2023https://modernod.com/news/market-scope-global-dry-eye-products-market-to-total-6-2-billion-in-2023/2476251/Providers of dry eye therapies can expect to see healthy growth in revenues overall in the next five years as people suffering from dry eye increasingly seek treatment. Market Scope looks for manufacturers’ global revenues in the dry eye treatments market to climb from $4.6 billion in 2018
- Study: Glaukos iStent inject Implantation with Concomitant Cataract Surgery Provides Sustained Reduction in IOP and Medication Burdenhttps://modernod.com/news/study-glaukos-istent-inject-implantation-with-concomitant-cataract-surgery-provides-sustained-reduction-in-iop-and-medication-burden/2479620/Glaukos announced that a single-site international study of glaucoma subjects recently published in Ophthalmology and Therapy showed that the iStent inject Trabecular Micro-Bypass System, combined with cataract surgery, achieved a 37% reduction in mean IOP to 14.3 mmHg after 3 years of f
- Envision Conference to Split in Two in 2019https://modernod.com/news/envision-conference-to-split-in-two-in-2019/2479634/For the first time since its inception in 2006, Envision Conference will be split into two events for the upcoming year: Envision Conference East, March 22-23, 2019 at the University of Alabama at Birmingham in Birmingham, Alabama; and Envision Conference West, October 5-6, 2019 at the College of
- SECO 2019 Puts Spotlight On Vision Industry Trendshttps://modernod.com/news/seco-2019-puts-spotlight-on-vision-industry-trends/2479643/SECO 2019 will lead the conversation on the latest vision industry trends when SECO 2019 takes place February 20-24, 2019 in New Orleans. From the latest technological innovations in eye and healthcare to up-and-coming eyewear products, SECO 2019 is where the optometric community of professional
- Acuvue Oasys with Transitions Light Intelligent Technology Named Among TIME’s ‘Best Inventions of 2018’https://modernod.com/news/acuvue-oasys-with-transitions-light-intelligent-technology-named-among-times-best-inventions-of-2018/2479661/TIME has selected Acuvue Oasys with Transitions Light Intelligent Technology as one of the ‘Best Inventions of 2018,’ in its annual round-up spotlighting groundbreaking innovations worldwide. The development of Acuvue Oasys with Transitions has created and defined an entirely new cate
- Recipients of the 2018 OWL Awards Recognized for Advancing Diversity in Ophthalmology Leadershiphttps://modernod.com/news/recipients-of-the-2018-owl-awards-recognized-for-advancing-diversity-in-ophthalmology-leadership/2479662/OWL: Advancing Diversity in Leadership (OWL) announced the winners of the 2018 OWL Awards at the organization’s Signature Event, which was held October 28 in Chicago during the annual meeting of the American Academy of Ophthalmology (AAO 2018). OWL presents the awards each year to those who best